These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27029809)

  • 1. The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease.
    Knapp DJ; Breese GR
    Curr Top Behav Neurosci; 2016; 29():265-277. PubMed ID: 27029809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat.
    Breese GR; Criswell HE; Duncan GE; Mueller RA
    Brain Res Bull; 1990 Sep; 25(3):477-84. PubMed ID: 2127238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
    Allen SM; Freeman JN; Davis WM
    Pharmacol Biochem Behav; 1998 Feb; 59(2):327-30. PubMed ID: 9476977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome.
    Stodgell CJ; Loupe PS; Schroeder SR; Tessel RE
    Brain Res; 1998 Feb; 783(1):10-8. PubMed ID: 9479035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine.
    Criswell H; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Mueller RA
    Pharmacol Biochem Behav; 1984 Sep; 21(3):459-61. PubMed ID: 6436840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.
    Baumeister AA; Frye GD
    Neurosci Biobehav Rev; 1985; 9(2):169-78. PubMed ID: 3925393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of Lesch-Nyhan syndrome.
    Jinnah HA; Gage FH; Friedmann T
    Brain Res Bull; 1990 Sep; 25(3):467-75. PubMed ID: 2292045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome.
    Allen SM; Davis WM
    Behav Pharmacol; 1999 Sep; 10(5):467-74. PubMed ID: 10780253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.
    Kuehn MR; Bradley A; Robertson EJ; Evans MJ
    Nature; 1987 Mar 19-25; 326(6110):295-8. PubMed ID: 3029599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.
    Arnold WJ; Meade JC; Kelley WN
    J Clin Invest; 1972 Jul; 51(7):1805-12. PubMed ID: 4624352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deficiencies of hypoxanthine guanine phosphoribosyltransferase (HPRT)].
    Yamada Y
    Nihon Rinsho; 2008 Apr; 66(4):687-93. PubMed ID: 18409516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the HPRT1 gene in 35 Italian Lesch-Nyhan families: 45 patients and 77 potential female carriers.
    de Gemmis P; Anesi L; Lorenzetto E; Gioachini I; Fortunati E; Zandonà G; Fanin E; Fairbanks L; Andrighetto G; Parmigiani P; Dolcetta D; Nyhan WL; Hladnik U
    Mutat Res; 2010 Oct; 692(1-2):1-5. PubMed ID: 20638392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Japanese family with Lesch-Nyhan syndrome resulting from a new point mutation in hypoxanthine-guanine phosphoribosyltransferase gene].
    Maruta K; Ohi T; Yamada Y; Goto H; Ogasawara N; Matsukura S
    No To Shinkei; 1997 Nov; 49(11):1009-13. PubMed ID: 9396032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome.
    Yeh J; Zheng S; Howard BD
    J Neurosci Res; 1998 Jul; 53(1):78-85. PubMed ID: 9670994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete and partial deficiency of HPRT].
    Ogasawara N
    Nihon Rinsho; 1996 Dec; 54(12):3315-20. PubMed ID: 8976112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.